Abstract:Viral diseases are a major threat to modern society and the global health system. It is therefore of utter relevance to understand the way viruses affect the host as a basis to find new treatment solutions. The understanding of viral myocarditis (VMC) is incomplete and effective treatment options are lacking. This review will discuss the mechanism, effects, and treatment options of the most frequent myocarditis-causing viruses namely enteroviruses such as Coxsackievirus B3 (CVB3) and Parvovirus B19 (PVB19) on the human heart. Thereby, we focus on: 1. Viral entry: CVB3 use Coxsackievirus-Adenovirus-Receptor (CAR) and Decay Accelerating Factor (DAF) to enter cardiac myocytes while PVB19 use the receptor globoside (Gb4) to enter cardiac endothelial cells. 2. Immune system responses: The innate immune system mediated by activated cardiac toll-like receptors (TLRs) worsen inflammation in CVB3-infected mouse hearts. Different types of cells of the adaptive immune system are recruited to the site of inflammation that have either protective or adverse effects during VMC. 3. Autophagy: CVB3 evades autophagosomal degradation and misuses the autophasomal pathway for viral replication and release. 4. Viral replication sites: CVB3 promotes the formation of double membrane vesicles (DMVs), which it uses as replication sites. PVB19 uses the host cell nucleus as the replication site and uses the host cell DNA replication system. 5. Cell cycle manipulation: CVB3 attenuates the cell cycle at the G1/S phase, which promotes viral transcription and replication. PVB19 exerts cell cycle arrest in the S phase using its viral endonuclease activity. 6. Regulation of apoptosis: Enteroviruses prevent apoptosis during early stages of infection and promote cell death during later stages by using the viral proteases 2A and 3C, and viroporin 2B. PVB19 promotes apoptosis using the non-structural proteins NS1 and the 11 kDa protein. 7. Energy metabolism: Dysregulation of respiratory chain complex expression, activity and ROS production may be altered in CVB3- and PVB19-mediated myocarditis. 8. Ion channel modulation: CVB3-expression was indicated to alter calcium and potassium currents in Xenopus laevis oocytes and rodent cardiomyocytes. The phospholipase 2-like activity of PVB19 may alter several calcium, potassium and sodium channels. By understanding the general pathophysiological mechanisms of well-studied myocarditis-linked viruses, we might be provided with a guideline to handle other less-studied human viruses.

Immunological mechanisms in myocarditis

[The Expression of Connexin 43 and Desmin in Viral Myocarditis].

Weighted Gene Co-Expression Network Analysis Identified Underlying Hub Genes and Mechanisms in the Occurrence and Development of Viral Myocarditis

Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes As an in Vitro Model for Coxsackievirus B3-Induced Myocarditis and Antiviral Drug Screening Platform

Mechanisms and Therapeutic Strategies of Viral Myocarditis Targeting Autophagy

Viral myocarditis: From molecular mechanisms to therapeutic prospects

Virus-Host Interactions of Enteroviruses and Parvovirus B19 in Myocarditis

Interaction Between Monocyte Chemoattractant Protein-1 (MCP-1) and CVB3 in Pathogenesis of Viral Myocarditis

Chemokine expression profile and its implications in viral myocarditis

The process and mechanisms of dendritic cells' migration in viral myocarditis

Manipulating Intestinal Immunity and Microflora: an Alternative Solution to Viral Myocarditis?

Coxsackievirus B3 Infection Induced Viral Myocarditis by Regulating the Expression Pattern of Chemokines in Cardiac Myocytes.

Immunopathogenesis and immunomodulatory therapy for myocarditis

Detection of Cytomegalovirus Genome by In-Situ Hybridization in Paraffin-Embedded Endomyocardial Biopsy Specimens of Viral Myocarditis

The Role of B Cells in Regulation of Th Cell Differentiation in Coxsackievirus B3-Induced Acute Myocarditis

Role of Coxsackievirus B3-Induced Immune Responses in the Transition from Myocarditis to Dilated Cardiomyopathy and Heart Failure

Identification of the communal pathogenesis and immune landscape between viral myocarditis and dilated cardiomyopathy

Pathogenesis of coxsackievirus B3-induced myocarditis: role of macrophage migration inhibitory factor.

Coxsackie B virus-induced myocarditis in a patient with a history of lymphoma: A case report and review of literature

Blocking Monocyte Chemoattractant Protein- 1 (MCP- 1 ) Alleviates Cardiac Lesion of Viral Myocarditis

Coxsackievirus B 3 modulates expression of CCN 5 / Wisp 2 in vivo and in vitro